Tealwood Asset Management’s Corcept Therapeutics CORT Stock Holding History

Tealwood Asset Management’s Portfolio CORT Stock Details CORT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-14,370	Closed	-$500K	–	120
2025 Q4	$500K	Sell	14,370 -16,786	-54%	-$1.32M	0.22%	115
2025 Q3	$2.59M	Buy	31,156 +11,433	+58%	+$827K	1.05%	30
2025 Q2	$1.45M	Sell	19,723 -95	-0.5%	-$6.89K	0.64%	79
2025 Q1	$2.26M	Buy	+19,818	New	+$1.21M	1.05%	34
2019 Q2	–	Sell	-154,615	Closed	-$1.81M	–	99
2019 Q1	$1.81M	Buy	154,615 +52,069	+51%	+$647K	0.77%	72
2018 Q4	$1.37M	Sell	102,546 -32,912	-24%	-$435K	0.65%	72
2018 Q3	$1.9M	Sell	135,458 -790	-0.6%	-$11K	0.71%	69
2018 Q2	$2.14M	Buy	+136,248	New	+$2.37M	0.84%	55

Other funds holding CORT

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

ISL

Ingalls & Snyder LLC New York $2.83B AUM 21.61% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Parallel Advisors San Francisco, California $6.56B AUM 32.24% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

First Trust Advisors Wheaton, Illinois $140B AUM 27.84% 1-Year Est. Return

Tealwood Asset Management's CORT Position: Q1 2026 in Review

Tealwood Asset Management sold out of Corcept Therapeutics (CORT) in Q1 2026, closing a stake of 14,370 shares — an estimated $500K sold.

Tealwood Asset Management first reported a position in CORT in Q2 2018 and held it in 8 quarters. The position peaked at $2.59M in Q3 2025. 351 funds tracked by Wall St. Rank hold CORT as of Q1 2026.

Tealwood Asset Management reported no remaining Corcept Therapeutics position as of Q1 2026 after selling out during the quarter.
Tealwood Asset Management sold 14,370 Corcept Therapeutics shares in Q1 2026, an estimated $500K.
Tealwood Asset Management first reported a position in Corcept Therapeutics in Q2 2018 and held it in 8 quarters.
Tealwood Asset Management's Corcept Therapeutics position peaked at $2.59M in Q3 2025.
351 funds tracked by Wall St. Rank held Corcept Therapeutics as of Q1 2026.

Based on Tealwood Asset Management's 13F filing for Q1 2026, filed 9 Apr 2026.